Medicare & Medicaid Guide P 44,735 Naveed A. Siddiqi v. United States

98 F.3d 1427, 1996 U.S. App. LEXIS 28125, 1996 WL 627803
CourtCourt of Appeals for the Second Circuit
DecidedOctober 31, 1996
Docket984, Docket 95-2174
StatusPublished
Cited by5 cases

This text of 98 F.3d 1427 (Medicare & Medicaid Guide P 44,735 Naveed A. Siddiqi v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Medicare & Medicaid Guide P 44,735 Naveed A. Siddiqi v. United States, 98 F.3d 1427, 1996 U.S. App. LEXIS 28125, 1996 WL 627803 (2d Cir. 1996).

Opinion

WINTER, Circuit Judge:

Naveed Siddiqi, M.D., appeals from Judge Telesca’s denial of his petition under 28 U.S.C. § 2255 to vacate his conviction and his sentence for Medicare billing fraud. Siddiqi asserts that he was convicted because of constitutionally ineffective assistance of counsel at trial. We find no merit in his ineffective assistance claim, but we nevertheless vacate his conviction and sentence. The government has, throughout this prosecution, adopted shifting theories of guilt. This inconstancy of position impeded Siddiqi’s defense at trial and has severely hampered judicial consideration of this matter. At this *1428 final stage, in order to rebut a claim of ineffective assistance, the government now embraces a theory that is legally insufficient. A miscarriage of justice having occurred, we vacate the conviction.

1. Background

Siddiqi is an oncologist who, at pertinent times, practiced medicine in Elmira, New York. He was board-certified in internal medicine, oncology, and hematology. In 1973, he was approved to participate as a physician in Medicare, the federally funded health insurance program that provides basic medical coverage to individuals over age 65 and to other qualified individuals.

The Medicare program is overseen by the Health Care Financing Administration (“HCFA”), part of the United States Department of Health and Human Services (“HHS”). Medicare is divided into two parts, commonly known as “Part A” and “Part B.” Part A covers health care services rendered primarily by hospitals, while Part B covers services rendered by physicians and other noninstitutional providers. HCFA contracts with private insurance companies across the country to process the claims submitted under Medicare. In the Elmira area, Blue Shield of Western New York (“Blue Shield”) administers Part B of the Medicare program.

Participating physicians and other Medicare providers submit claims by mail or computer to Blue Shield. In submitting claims for reimbursement, providers use Blue Shield’s Doctor’s Manual, a three-inch-thick looseleaf binder containing various descriptions of medical services and five-digit numerical codes. Each provider selects from the Manual the code that most accurately describes the services rendered. After processing the claim, Medicare mails the check to the physician. A deliberately misleading use of a particular code would, of course, support a criminal fraud charge under various federal statutes. See, e.g., 18 U.S.C. § 1341; 18 U.S.C. § 287; 18 U.S.C. § 1001.

2. The Indictment and Pretrial Proceedings

In 1990, a grand jury in the Western District of New York returned an indictment charging Siddiqi with 77 counts of fraud related to his Medicare billing practices between March 11, 1988 and April 27, 1989. Each count of the indictment involved one of three separate allegedly fraudulent schemes. The jury acquitted Siddiqi on every count related to two of the schemes. It convicted on five counts involving a scheme in which Siddiqi submitted allegedly false Medicare claims for chemotherapy treatments. These counts were for mail fraud, in violation of 18 U.S.C. § 1341; theft of government property, in violation of 18 U.S.C. § 641; and false claims, in violation of 18 U.S.C. § 287.

The five counts of conviction alleged that Siddiqi defrauded the Medicare program by submitting claims for outpatient chemotherapy treatments that he prescribed for his patients and that were administered by the medical staff at St. Joseph’s Hospital. The indictment stated that “no chemotherapy treatment was administered to [Siddiqi’s patients] at his office on the same day that the patient received chemotherapy treatment at the hospital.” It further stated that the hospital chemotherapy was “administered without [Siddiqi’s] participation or supervision” and that Siddiqi “caused claims to be submitted ... for the administration of chemotherapy well knowing that chemotherapy was solely administered on that day to the patient at St. Joseph’s Hospital during which time [Sid-diqi] was not participating in or supervising the administration of the chemotherapy.” Finally, the indictment charged that Siddiqi “knew St. Joseph’s Hospital would file a claim to the Medicare program for the chemotherapy” and that Siddiqi thus “caused the duplicate claims for chemotherapy treatment ... in order to receive additional monies from Medicare.”

These counts all related to claims submitted for services in connection with chemotherapy treatments administered to patients between July 12, 1988 and July 28, 1988. The parties stipulated that Siddiqi, a Mos-lem, was on a pilgrimage to Mecca during that time. We will, therefore, style these five counts the “Mecca counts.”

3.The Trial

In his opening statement, the prosecutor advanced a simple theory as to the Mecca *1429 counts: “This case is really all about Medicare fraud; phony billing, billing for services not rendered .... [t]he doctor submitted a claim to Medicare saying, in essence, T performed that chemo. So I’m entitled to reimbursement for the cost of the administration of that chemo, for the cost of the drug and for the cost of the actual administering the chemo.’ ” Siddiqi, the government asserted, was “claiming for services rendered by somebody else.”

The prosecution’s opening statement thus presented a simple theory of double billing: St. Joseph’s billed Medicare for the cost of the drug and of administering it, while Siddi-qi billed Medicare for the very same things. If proven, of course, Siddiqi would indeed be guilty of fraud no matter where he was at the time the chemotherapy was administered. Indeed, the prosecutor’s opening never referred to Siddiqi’s whereabouts at times pertinent to the Mecca counts.

However, the opening statement was a harbinger of the way in which this prosecution was to be conducted. The double billing theory was grand advocacy but had no basis in the evidence.

First, the Mecca counts involved Siddiqi’s use of code 96500 in the Blue Shield Doctor’s Manual to bill for the chemotherapy treatments in question. To convict Siddiqi on any of the Mecca counts, the government had to show knowing falsity in using that code. However, code 96500 does not state that it covers the cost of the chemotherapy drug itself. Siddiqi’s use of that code was not a statement, therefore, that he had provided the drug and was seeking reimbursement for its cost.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Dimattina
885 F. Supp. 2d 572 (E.D. New York, 2012)
Graves v. Roe
39 F. App'x 521 (Ninth Circuit, 2002)
Gerald Ross Pizzuto, Jr. v. A.J. Arave, Warden
280 F.3d 949 (Ninth Circuit, 2002)
United States v. Bonham
Fifth Circuit, 1999

Cite This Page — Counsel Stack

Bluebook (online)
98 F.3d 1427, 1996 U.S. App. LEXIS 28125, 1996 WL 627803, Counsel Stack Legal Research, https://law.counselstack.com/opinion/medicare-medicaid-guide-p-44735-naveed-a-siddiqi-v-united-states-ca2-1996.